Navigation Links
Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients
Date:6/5/2008

- Phase II Data Indicate Overall and Disease-Free Survival -

WAYNE, N.J., June 5 /PRNewswire/ -- Results from an adjuvant trial in high-risk melanoma patients demonstrated that a majority of patients treated with Leukine(R) (sargramostim) achieved disease-free and/or overall survival. These findings, which indicate Leukine's potential in this cancer setting, were released at the 44th annual meeting of the American Society of Clinical Oncology (ASCO).

Results from the Phase II study (ASCO abstract #20027) show that 60 percent of the 45 high-risk patients enrolled in the trial experienced disease-free survival and 64 percent of patients achieved overall survival at 21 months.

"Previous findings suggest that sargramostim may be a potential adjuvant therapy for high-risk melanoma patients," said E. George Elias M.D., Ph.D., Director of Maryland Melanoma Center. "The percentage of patients who achieved disease-free and overall survival in this trial provides further evidence that sargramostim may prove to be a viable treatment option for this patient population and that further study in Phase III trials are needed."

In this trial, adjuvant therapy with Leukine and a synergistic cytokine, IL-2, was generally well-tolerated in patients with high-risk melanoma following potentially curative surgery. Each patient received two years of adjuvant therapy: year one with Leukine and IL-2 and year two with only Leukine. Toxicities were mild to moderate and no hospitalizations were required.

"These data, particularly the overall survival rates, are encouraging, even though preliminary, and indicate Leukine's potential as a treatment in this setting," said Paul MacCarthy, M.D., FRCPI, vice president and head of U.S. Medical Affairs for Bayer HealthCare Pharmaceuticals.

Clinical Trial Overview

This Phase II trial was a single-arm, open-labeled study to evaluate the safety, tolerability and treatment efficacy of Leukine and I
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors
2. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
3. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
4. Wound Management Technologies, Inc. Announces Evidence Based Study
5. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
6. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
7. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
8. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
9. Study Findings Show Infection Control Intervention Helps Keep Kids in School
10. Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function
11. Study Finds Disparities in Breast Cancer Treatment Even Among Fully-Insured African-American and Caucasian Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... EU5 Esophagoscopes & Gastroscopes Market Outlook ... "EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020", ... & Gastroscopes market. The report provides value, in ... average prices (in US dollars) within market segments ... and Flexible Video Gastroscopes. The ...
(Date:9/29/2014)... , September 29, 2014 ... US$ 21.1 billion by 2018, recording a CAGR of ... Drug Delivery Devices Market - Global Industry Analysis, Size, ... Market Research, a U.S.-based market intelligence company. ... will benefit from an increasing occurrence of cardiovascular diseases, ...
(Date:9/29/2014)...  On Oct. 2, some 24,000 Lilly employees spanning ... Global Day of Service. Building on Lilly,s strong heritage ... a single, coordinated effort to improve the communities where ... so proud of this tradition, and of our Lilly ... the communities around the world where we live and ...
Breaking Medicine Technology:EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 3Global Implantable Drug Delivery Devices Market to Grow at 8.8% CAGR to US$ 21.1 billion by 2018: Transparency Market Research 2Global Implantable Drug Delivery Devices Market to Grow at 8.8% CAGR to US$ 21.1 billion by 2018: Transparency Market Research 3Global Implantable Drug Delivery Devices Market to Grow at 8.8% CAGR to US$ 21.1 billion by 2018: Transparency Market Research 4Lilly's seventh Global Day of Service rallies 24,000 employees in nearly 60 countries 2Lilly's seventh Global Day of Service rallies 24,000 employees in nearly 60 countries 3
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... officials in FDA,s Office of New Drugs (OND), the ... a cardiovascular outcomes trial (CVOT) for Contrave® that would ... 2011. Orexigen believes that these design requirements are reasonable ...
... CLEVELAND, Sept. 20, 2011 Dr. Melisa Estes, who is ... suffer from chronic knee pain. She recently began incorporating a ... nerve stimulation, also known as TENS, sends electrical stimulation to ... signals from reaching the brain, and that reduces pain. ...
Cached Medicine Technology:Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 2Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 3Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 4Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 5Knee Pain Control - No Drugs - Doctor Used 2
(Date:9/29/2014)... 2014 NAPW honors ... Heaven Sent Consultation , as a 2014 Professional ... this prestigious distinction for leadership in marriage and family ... women in the country, spanning virtually every industry and ... powerfully vibrant networking community with over 600,000 members and ...
(Date:9/29/2014)... Top10BestSEOHosting.com is a website dedicated to providing up-to-date ... headed by a team of experts and professionals ... and factual studies about the newest hosting products, ... , Top10BestSEOHosting.com has recently compared many Linux hosting ... and Bluehost are the most recommended suppliers for ...
(Date:9/29/2014)... (PRWEB) September 30, 2014 According to ... dates back more than 5000 years, and was worn ... Europe, when women's fashions moved in the direction of ... moving in another direction. Today, Fecbek, a leading online ... of men’s handbags. The new items are fashionable. ...
(Date:9/29/2014)... New York, NY (PRWEB) September 29, 2014 ... parenthood. Some parents get lucky when there little one can ... peep and takes consistent naps each day. For many parents, ... to perform if you're exhausted and consumed with stress. ... just assumed that like other babies she would fall ...
(Date:9/29/2014)... TX (PRWEB) September 29, 2014 Dr. ... for over 25 years in his hometown, returns to ... general Neurosurgical and Spine Center. , Over the last ... Darnall Army Hospital at Fort Hood and Lubbock. He ... of Neurosurgical Excellence devoted to the goal of excellence ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Carmel T. Ross, Marriage and Family Therapist at Heaven Sent Consultation, a 2014 Professional Woman of the Year 2Health News:Top10BestSEOHosting.com: New Reviews for Linux Web Hosting Suppliers Available Online 2Health News:Mommy Blogger Offers Advice on Getting Your Baby to Sleep 2Health News:Mommy Blogger Offers Advice on Getting Your Baby to Sleep 3Health News:Houston Neuro & Spine Surgery Plans to Develop Center of Neurosurgical Excellence 2
... study says, and that early exposure influences young people to ... Young people who start smoking may be influenced to do ... suggests. , What,s more, the study found that almost 80 ... through films rated "G," "PG" and "PG-13." , "Movies seen ...
... to Prevent Sudden Cardiac Arrest Through Public,Education and Advocacy, ... (SCAA) announced today that it has launched a South ... to help carry out its,mission of preventing sudden cardiac ... by Elliot Fisch of Boca Raton, Florida,who has long ...
... Will Work to Prevent Sudden Cardiac Arrest, Through ... The Sudden Cardiac Arrest,Association (SCAA) announced today that it ... network of local organizations to help carry out,its mission ... SCAA chapter is led by Connie Snell of Austin ...
... Life Coach Sherri Ziff Lester Says Small Steps Are Key to Gradual ... New Year,s Resolution Success, ... to lose weight, quit smoking or eat healthier for the,next 365 days. ... there seemed to be a shortage of fresh fruit and veggies at,grocery ...
... Older men with chronic anxiety are at substantially higher risk, ... men who suffer from chronic anxiety substantially increase their risk ... While stress has been linked to an increased risk of ... has been identified as a risk factor also. , "There ...
... 7, 2007 Scientists at Washington University School of ... better understand a collection of proteins associated with the ... movement. , The cell,s ability to move is important ... how immune system cells pursue disease-causing invaders and how ...
Cached Medicine News:Health News:Smoking in Movies Linked to Kids Lighting Up 2Health News:Smoking in Movies Linked to Kids Lighting Up 3Health News:Sudden Cardiac Arrest Association Launches South Florida Chapter 2Health News:Sudden Cardiac Arrest Association Launches South Florida Chapter 3Health News:Sudden Cardiac Arrest Association Launches Austin and Lubbock Chapters 2Health News:Sudden Cardiac Arrest Association Launches Austin and Lubbock Chapters 3Health News:Ring In 2008 With Simple New Year's Resolutions That Will Stick Year-Round 2Health News:Ring In 2008 With Simple New Year's Resolutions That Will Stick Year-Round 3Health News:Anxiety Raises Heart Attack Risk 2Health News:Anxiety Raises Heart Attack Risk 3Health News:Insights into cell movement likely to aid immune study, cancer research 2Health News:Insights into cell movement likely to aid immune study, cancer research 3
... CSZ safely provides effective air warming therapy ... patented design of our WarmAir® FilteredFlo® blankets, ... which supplies gently moving, clean air that ... contaminants to your patient or staff. All ...
The Synoptiscope(L-2510B) has a wide variety of functions including binocular function diagnosis and treatment....
Holligard protects skin from irritating stomal discharge. Holligard is flexible and durable in heat and humidity....
Inquire...
Medicine Products: